A provider's guide to vascular disease, dyslipidemia, and glycemic dysregulation in chronic spinal cord injury
M Stillman, S Babapoor-Farrokhran… - Topics in spinal …, 2020 - meridian.allenpress.com
… et al demonstrated that extended-release niacin is a safe and … glucose tolerance (IGT) on
oral glucose tolerance tests (OGTT)… been no prospective clinical trials demonstrating reductions …
oral glucose tolerance tests (OGTT)… been no prospective clinical trials demonstrating reductions …
[PDF][PDF] Cardiometabolic disease and dysfunction following spinal cord injury: origins and guideline-based countermeasures
MS Nash, DR Gater Jr - Physical medicine and rehabilitation clinics of North …, 2020 - Elsevier
… Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia
risks in persons with chronic tetraplegia: a randomized multicenter controlled trial. Arch …
risks in persons with chronic tetraplegia: a randomized multicenter controlled trial. Arch …
Bioactive role of vitamins as a key modulator of oxidative stress, cellular damage and comorbidities associated with spinal cord injury (SCI)
KA Pedroza-García, G Careaga-Cárdenas… - Nutritional …, 2023 - Taylor & Francis
… Results: Consistent benefits in clinical trials were shown in those who were supplemented
… Moreover, SCI patients with dyslipidemia who were supplemented with niacin monotherapy …
… Moreover, SCI patients with dyslipidemia who were supplemented with niacin monotherapy …
Diagnosis and Management of Cardiovascular Risk in Individuals With Spinal Cord Injury: A Narrative Review
… cardiovascular disease risk factors, including dyslipidemia and … pressure monitoring in
people with both tetraplegia (cervical … Niacin is not recommended for treatment of lipid disorders …
people with both tetraplegia (cervical … Niacin is not recommended for treatment of lipid disorders …
Importance of prospective registries and clinical research networks in the evolution of spinal cord injury care
… Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia
risks in persons with chronic tetraplegia: a randomized multicenter controlled trial. Arch …
risks in persons with chronic tetraplegia: a randomized multicenter controlled trial. Arch …
Characterization of gastrointestinal hormone dysfunction and metabolic pathophysiology in experimental spinal cord injury
… Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia
risks in persons with chronic tetraplegia: a randomized multicenter controlled trial. Arch …
risks in persons with chronic tetraplegia: a randomized multicenter controlled trial. Arch …
Cardiometabolic risks and atherosclerotic disease in ApoE knockout mice: Effect of spinal cord injury and Salsalate anti-inflammatory pharmacotherapy
GE Bigford, A Szeto, J Kimball, EE Herderick… - PloS one, 2021 - journals.plos.org
… associated risk factors, and anti-inflammatory treatment may … ‘dyslipidemia’ after SCI is
uniquely responsible for AD risk in … and randomized placebo-controlled studies demonstrate that …
uniquely responsible for AD risk in … and randomized placebo-controlled studies demonstrate that …
Anti-epileptic medications
M Maroney, M Markovic - Side Effects of Drugs Annual, 2022 - Elsevier
… that resulted in immediate tetraplegia. He developed lower … Thirty pediatric patients taking
valproate monotherapy for at … A 42 YOF with an overdose of extended-release valproate was …
valproate monotherapy for at … A 42 YOF with an overdose of extended-release valproate was …
[PDF][PDF] Advance Research Trends in Medical and Clinical Sciences Volume-1
N Singh, C Madhavrao - researchgate.net
… in balance and risk of falls is twice or thrice more in patients with DPN. [11] Deficits in … using
daily screening trial of oral feeds with HFNC support in selected patients of severe COVID-19 …
daily screening trial of oral feeds with HFNC support in selected patients of severe COVID-19 …
Guía para médicos de atención primaria sobre enfermedades vasculares, dislipidemia y desregulación glucémica en la lesión crónica de la médula espinal
M Stillman… - Top Spinal Cord Inj …, 2020 - meridian.allenpress.com
… Intramuscular fat and glucose tolerance after spinal cord … -metabolic risk factors: An open-label
randomized clinical trial. J … in communitydwelling persons with chronic spinal cord injury…
randomized clinical trial. J … in communitydwelling persons with chronic spinal cord injury…